我要投票 新开河在人参行业中的票数:566
· 外 推 电 报 ·
2025-11-22 18:22:17 星期六

【新开河是哪个国家的品牌?】

新开河是什么牌子?「新开河」是 康美药业股份有限公司 旗下著名品牌。该品牌发源于吉林省通化市,由创始人马董在1997年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力新开河品牌出海!将品牌入驻外推网,定制新开河品牌推广信息,可以显著提高新开河产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

成立于1997年,较早布局中医药全产业,以中药饮片为核心,以智慧药房为抓手,打造大健康+大平台+大数据+大服务体系


康美药业股份有限公司(600518)成立于1997年,于2001年在上交所上市。公司秉承“心怀苍生、大爱无疆”的核心价值观和“用爱感动世界、用心经营健康”的经营理念,在国家振兴中医药事业战略指引下,较早布局中医药全产业,以中药饮片为核心,以智慧药房为抓手,打造“大健康+大平台+大数据+大服务”体系,成为中医药全产业链服务型“智慧+”大健康产业上市企业。

康美药业上至药材种植、药材交易,下至生产开发、终端销售,已基本贯穿中医药产业链的上、中、下游产业,业务渗透中医药全产业链的各个关键环节,有效地整合全产业链资源。公司先后在全国各地投资建立140多家涵盖药材种植、中药材交易市场、现代物流中心和产业基地等业务的企业。

在全国建立了17个中药饮片和医药现代化生产基地,与超过2000家医疗机构、20万家药店建立了合作关系,年门诊总量达到2.5亿人次以上,投资管理康美医院、康美梅河口中心医院、康美通辽医院、康美开原市中心医院、康美通城人民医院、康美柳河中心医院等多家公立医院,在100多家公立医院开展医药物流延伸配送服务。

公司以国家中医药管理局信息化医疗服务平台试点单位为契机,把互联网深度布局全产业链中,以中药饮片为核心,以智慧药房为抓手,围绕“大健康+大平台+大数据+大服务”体系,以全产业链资源优势,积极探索中医药工业智能制造4.0,较早打造“智慧药房”模式。“智慧药房”模式上升为行业标准,为患者提供了“一站式”药事服务。截止2018年三季度,康美智慧药房累计处方量710万张,服务患者250万人,实现了“让信息多跑路,让群众少跑腿”。

康美药业丰富的医疗资源为公司以互联网思维、技术,改造和升级传统医疗健康产业,打造具有优良用户体验、覆盖全生命周期、一站式完整医疗服务闭环的移动健康管理大平台,奠定了坚实的基础。


英文翻译:Founded in 1997, Kangmei Pharmaceutical Co., Ltd. (600518) was founded in 1997 and listed on the Shanghai Stock Exchange in 2001. It has an early layout of the whole industry of traditional Chinese medicine, with herbal pieces as the core and smart pharmacies as the starting point to build a big health + big platform + big data + big service system. The company adheres to the core values of "caring for the world, loving the boundless" and the business philosophy of "moving the world with love and managing health with heart". Under the guidance of the national strategy of rejuvenating the cause of traditional Chinese medicine, the whole industry of traditional Chinese medicine is laid out earlier, with Chinese herbal pieces as the core and smart pharmacies as the starting point, and the system of "big health + big platform + big data + big service" is built to become the whole industry of traditional Chinese medicine Chain service-oriented "wisdom +" large health industry listed enterprises. Kangmei pharmaceutical industry has basically run through the upstream, midstream and downstream industries of TCM industry chain from the planting and trading of medicinal materials to the production and development and terminal sales. Its business penetrates all key links of the whole industry chain of TCM and effectively integrates the resources of the whole industry chain. The company has successively invested and established more than 140 enterprises covering medicine planting, Chinese medicine trading market, modern logistics center and industrial base. It has established 17 modern production bases of Chinese herbal pieces and medicine, established cooperative relations with more than 2000 medical institutions and 200000 pharmacies, with an annual outpatient volume of more than 250 million person times, invested and managed many hospitals, including Kangmei hospital, Kangmei Meihekou Central Hospital, Kangmei Tongliao hospital, Kangmei Kaiyuan Central Hospital, Kangmei Tongcheng people's Hospital and Kangmei Liuhe central hospital Public hospitals, in more than 100 public hospitals to carry out pharmaceutical logistics extended distribution services. Taking the opportunity of the pilot unit of the informatization medical service platform of the State Administration of traditional Chinese medicine, the company takes the Internet as an in-depth layout in the whole industry chain, with Chinese herbal pieces as the core, smart pharmacy as the starting point, around the "big health + big platform + big data + big service" system, and with the resource advantages of the whole industry chain, actively explores the intelligent manufacturing 4.0 of the traditional Chinese medicine industry, and builds the "smart pharmacy" model earlier Type. The mode of "smart pharmacy" has risen to the industry standard, providing patients with "one-stop" pharmaceutical services. As of the third quarter of 2018, Kangmei smart pharmacy has accumulated 7.1 million prescriptions, served 2.5 million patients, and realized "let more information run more, let the masses run less". Kangmei pharmaceutical's rich medical resources have laid a solid foundation for the company to transform and upgrade the traditional medical and health industry with internet thinking and technology, and to build a mobile health management platform with excellent user experience, covering the whole life cycle and one-stop complete medical service closed-loop.

本文链接: https://www.waitui.com/brand/f1e75a350.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

澳大利亚将禁止机舱内使用充电宝

澳大利亚几家主要航空公司21日宣布,将于下月开始陆续禁止在航班上使用充电宝或为充电宝充电,以降低机舱内火灾风险。这些安全措施将适用于所有国内和国际航班,且不会给予任何豁免。据澳大利亚广播公司21日报道,澳洲航空公司及其旗下的澳航支线、捷星航空宣布将于12月15日起实施禁令,而维珍澳大利亚航空公司的禁令将从12月1日起执行。(财联社)

23分钟前

峰飞航空:累计获得eVTOL确认订单300架

11月22日消息,峰飞航空累计获得eVTOL商业订单2000架,其中,截至2025年底的确认订单是300架。(证券时报)

23分钟前

兆威机电、迈威生物港股IPO获中国证监会备案

11月22日消息,中国证监会国际合作司发布关于深圳市兆威机电股份有限公司、迈威(上海)生物科技股份有限公司境外发行上市备案通知书,兆威机电拟发行不超过69,058,450股境外上市普通股并在香港联合交易所上市。迈威生物拟发行不超过62,664,600股境外上市普通股并在香港联合交易所上市。(金十数据APP)

23分钟前

阿斯利康宣布投资20亿美元扩建马里兰州生产基地

当地时间11月21日,阿斯利康宣布计划投资20亿美元,用于扩建其位于马里兰州的长期生产基地。此项投资将为该州创造2600个就业岗位,包括保留当地现有职位、建筑活动相关岗位,以及新增300个高技能职位。(界面新闻)

23分钟前

我国卫星物联网业务商用试验正式启动

11月22日,在2025中国“5G+”工业互联网大会上,工业和信息化部对外宣布,我国卫星物联网业务商用试验正式启动。此次商用试验期为两年。目标通过开展商用试验,丰富卫星通信市场供给,激发市场主体活力,提升行业服务能力,建立安全监管体系,形成可复制可推广的经验和模式,支撑商业航天、低空经济等新兴产业安全健康发展,服务构建新发展格局。(第一财经)

23分钟前

本页详细列出关于新开河的品牌信息,含品牌所属公司介绍,新开河所处行业的品牌地位及优势。
咨询